David Erlinge, MD, PhD (he/him/his)

Professor, Consultant Interventional Cardiology
Lund University
Lund, Sweden

Dr David Erlinge is Professor of Cardiology at Lund University, Sweden Prof Erlinge is an interventional cardiologist focusing on PCI with a clinical interest in acute coronary syndromes. He is chairman of the Swedish PCI register (SCAAR) member of the board of SWEDEHEART.
He has been involved in the developing and leading registry based randomized clinical trials (RRCT) from TASTE, IFR-SWEDEHEART, DETO2X and was the leader of the pharmaceutical RRCT VALIDATE-SWEDEHEART and the diagnostic vunerable plaque trial PROSPECT II.

Presentation(s):

• Overview Presentation: Experience from Swedeheart Supporting Industry EU MDR Submissions

  Saturday, February 25, 2023
  9:00 AM – 9:10 AM ET

  Disclosure(s): Abbott Laboratories, Boston Scientific, Covidien, Janssen Pharmaceuticals, The Medicines Company, Sanofi-Aventis: Advisory Committee/Board Member (Ongoing); AstraZeneca: Clinical Trial Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bayer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BMS/Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sanofi: Scientific Advisory Board (Ongoing)

• Discussion Panel: What Could International Registry/ARO/CRO Collaborations with Industry for EU MDR Submissions look Like?

  Saturday, February 25, 2023
  9:10 AM – 9:45 AM ET

  Disclosure(s): Abbott Laboratories, Boston Scientific, Covidien, Janssen Pharmaceuticals, The Medicines Company, Sanofi-Aventis: Advisory Committee/Board Member (Ongoing); AstraZeneca: Clinical Trial Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bayer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BMS/Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sanofi: Scientific Advisory Board (Ongoing)

• Biomarkers of the Vulnerable Plaque

  Saturday, February 25, 2023
  2:48 PM – 2:56 PM ET

  Disclosure(s): Abbott Laboratories, Boston Scientific, Covidien, Janssen Pharmaceuticals, The Medicines Company, Sanofi-Aventis: Advisory Committee/Board Member (Ongoing); AstraZeneca: Clinical Trial Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bayer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BMS/Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sanofi: Scientific Advisory Board (Ongoing)

• Panel Discussion: Our Understanding on the Pathophysiology and Mechanism of Atherosclerosis and the VP in 2023

  Saturday, February 25, 2023
  2:56 PM – 3:11 PM ET

  Disclosure(s): Abbott Laboratories, Boston Scientific, Covidien, Janssen Pharmaceuticals, The Medicines Company, Sanofi-Aventis: Advisory Committee/Board Member (Ongoing); AstraZeneca: Clinical Trial Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bayer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BMS/Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sanofi: Scientific Advisory Board (Ongoing)

• ATHEROSCLEROSIS THERAPEUTIC OPTIONS AND MANAGEMENT

  Saturday, February 25, 2023
  4:06 PM – 5:35 PM ET

  Disclosure(s): Abbott Laboratories, Boston Scientific, Covidien, Janssen Pharmaceuticals, The Medicines Company, Sanofi-Aventis: Advisory Committee/Board Member (Ongoing); AstraZeneca: Clinical Trial Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bayer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BMS/Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sanofi: Scientific Advisory Board (Ongoing)

• Panel Discussion: Atherosclerosis Therapeutic Options and Management

  Saturday, February 25, 2023
  5:26 PM – 5:35 PM ET

  Disclosure(s): Abbott Laboratories, Boston Scientific, Covidien, Janssen Pharmaceuticals, The Medicines Company, Sanofi-Aventis: Advisory Committee/Board Member (Ongoing); AstraZeneca: Clinical Trial Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bayer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BMS/Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sanofi: Scientific Advisory Board (Ongoing)

• 5-Year Data from the SWEDHEART IFR Study

  Saturday, February 25, 2023
  3:47 PM – 3:55 PM ET

  Disclosure(s): Abbott Laboratories, Boston Scientific, Covidien, Janssen Pharmaceuticals, The Medicines Company, Sanofi-Aventis: Advisory Committee/Board Member (Ongoing); AstraZeneca: Clinical Trial Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bayer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BMS/Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sanofi: Scientific Advisory Board (Ongoing)

• Moderated Discussion

  Saturday, February 25, 2023
  4:27 PM – 4:40 PM ET

  Disclosure(s): Abbott Laboratories, Boston Scientific, Covidien, Janssen Pharmaceuticals, The Medicines Company, Sanofi-Aventis: Advisory Committee/Board Member (Ongoing); AstraZeneca: Clinical Trial Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bayer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BMS/Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sanofi: Scientific Advisory Board (Ongoing)

• DynamX Bioadaptor: Novel Coronary Prosthesis Enters IDE Trial

  Sunday, February 26, 2023
  4:22 PM – 4:30 PM ET

  Disclosure(s): Abbott Laboratories, Boston Scientific, Covidien, Janssen Pharmaceuticals, The Medicines Company, Sanofi-Aventis: Advisory Committee/Board Member (Ongoing); AstraZeneca: Clinical Trial Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bayer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BMS/Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sanofi: Scientific Advisory Board (Ongoing)

• Discussion: Is there a Role/Need for Bioresorbable and/or Bioadaptor Platforms?

  Sunday, February 26, 2023
  4:54 PM – 5:18 PM ET

  Disclosure(s): Abbott Laboratories, Boston Scientific, Covidien, Janssen Pharmaceuticals, The Medicines Company, Sanofi-Aventis: Advisory Committee/Board Member (Ongoing); AstraZeneca: Clinical Trial Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bayer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BMS/Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sanofi: Scientific Advisory Board (Ongoing)